In this study, the rate of lymph node metastasis in ERBB-2 positive patients was 67.2% (82/122), which is significantly higher than that in ERBB-2 negative patients, which was 48.4% (346/714). This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.